| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Sale | $192,210 | -1,247 | -32% | $154.14 | 2,634 | 04 Nov 2021 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $425,304 | +5,400 | +205% | $78.76 | 8,034 | 04 Nov 2021 | Direct | |
| transaction | CNMD | Common Stock | Sale | $834,624 | -5,400 | -67% | $154.56 | 2,634 | 04 Nov 2021 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $249,110 | +2,550 | +97% | $97.69 | 5,184 | 04 Nov 2021 | Direct | |
| transaction | CNMD | Common Stock | Sale | $394,268 | -2,550 | -49% | $154.62 | 2,634 | 04 Nov 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -5,400 | -40% | $0.000000 | 8,100 | 04 Nov 2021 | Common Stock | 5,400 | $78.76 | Direct | F2 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -2,550 | -20% | $0.000000 | 10,200 | 04 Nov 2021 | Common Stock | 2,550 | $97.69 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.53 to $154.64. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F2 | The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |